Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
SAB BiotherapeuticsSABS | Open-market buy | 23/12/07 | 23/12/08 | 1,740 sh | $0.88 | $1,531.2 | +0.0% | |
Michael KingCFO | SAB BiotherapeuticsSABS | Open-market buy | 23/11/30 | 23/11/30 | 5,000 sh | $0.90 | $4,500 | No record |
Samuel J. ReichExecutive Chairman | SAB BiotherapeuticsSABS | Open-market buy | 23/11/29 | 23/11/30 | 11,000 sh | $0.89 | $9,790 | +5.3% |